About this Journal Submit a Manuscript Table of Contents
Journal of Aging Research
Volume 2012 (2012), Article ID 384017, 21 pages
http://dx.doi.org/10.1155/2012/384017
Review Article

Insulin in Central Nervous System: More than Just a Peripheral Hormone

1CNC, Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal
2Institute of Physiology, Faculty of Medicine, University of Coimbra, 3000-354 Coimbra, Portugal
3Institute of Biochemistry, Faculty of Medicine, University of Coimbra, 3000-354 Coimbra, Portugal

Received 4 April 2011; Revised 12 October 2011; Accepted 23 November 2011

Academic Editor: Barbara Shukitt-Hale

Copyright © 2012 Ana I. Duarte et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Fulop, A. Larbi, and N. Douziech, “Insulin receptor and ageing,” Pathologie Biologie, vol. 51, no. 10, pp. 574–580, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. R. J. Schulingkamp, T. C. Pagano, D. Hung, and R. B. Raffa, “Insulin receptors and insulin action in the brain: review and clinical implications,” Neuroscience and Biobehavioral Reviews, vol. 24, no. 8, pp. 855–872, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. Z. Laron, “Insulin and the brain,” Archives of Physiology and Biochemistry, vol. 115, no. 2, pp. 112–116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Erol, “An integrated and unifying hypothesis for the metabolic basis of sporadic Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 13, no. 3, pp. 241–253, 2008. View at Scopus
  5. M. Salkovic-Petrisic and S. Hoyer, “Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach,” Journal of Neural Transmission, no. 72, pp. 217–233, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. R. U. Margolis and N. Altszuler, “Insulin in the cerebrospinal fluid,” Nature, vol. 215, no. 5108, pp. 1375–1376, 1967. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Schechter, J. Whitmire, L. Holtzclaw, M. George, R. Harlow, and S. U. Devaskar, “Developmental regulation of insulin in the mammalian central nervous system,” Brain Research, vol. 582, no. 1, pp. 27–37, 1992. View at Publisher · View at Google Scholar · View at Scopus
  8. D. LeRoith, “CNS regulation of carbohydrate metabolism,” in Advances in Metabolic Disorders, A. Szabo, Ed., vol. 10, pp. 304–340, Academic Press, 1983.
  9. J. M. Burns, J. E. Donnelly, H. S. Anderson et al., “Peripheral insulin and brain structure in early Alzheimer disease,” Neurology, vol. 69, no. 11, pp. 1094–1104, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. W. A. Banks, “The source of cerebral insulin,” European Journal of Pharmacology, vol. 490, no. 1–3, pp. 5–12, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. P. I. Moreira, A. I. Duarte, M. S. Santos, A. C. Rego, and C. R. Oliveira, “An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 16, no. 4, pp. 741–761, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Freude, L. Plum, J. Schnitker et al., “Peripheral hyperinsulinemia promotes tau phosphorylation in vivo,” Diabetes, vol. 54, no. 12, pp. 3343–3348, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Sankar, S. Thamotharan, D. Shin, K. H. Moley, and S. U. Devaskar, “Insulin-responsive glucose transporters—GLUT8 and GLUT4 are expressed in the developing mammalian brain,” Molecular Brain Research, vol. 107, no. 2, pp. 157–165, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Porte, R. J. Seeley, S. C. Woods, D. G. Baskin, D. P. Figlewicz, and M. W. Schwartz, “Obesity, diabetes and the central nervous system,” Diabetologia, vol. 41, no. 8, pp. 863–881, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Zhao, H. Chen, H. Xu et al., “Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats,” Journal of Biological Chemistry, vol. 274, no. 49, pp. 34893–34902, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Schechter, T. Yanovitch, M. Abboud, G. Johnson, and J. Gaskins, “Effects of brain endogenous insulin on neurofilament and MAPK in fetal rat neuron cell cultures,” Brain Research, vol. 808, no. 2, pp. 270–278, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Craft, J. Newcomer, S. Kanne et al., “Memory improvement following induced hyperinsulinemia in Alzheimer's disease,” Neurobiology of Aging, vol. 17, no. 1, pp. 123–130, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Schechter, D. Beju, T. Gaffney, F. Schaefer, and L. Whetsell, “Preproinsulin I and II mRNAs and insulin electron microscopic immunoreaction are present within the rat fetal nervous system,” Brain Research, vol. 736, no. 1-2, pp. 16–27, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Schechter, H. F. Sadiq, and S. U. Devaskar, “Insulin and insulin mRNA are detected in neuronal cell cultures maintained in an insulin-free/serum-free medium,” Journal of Histochemistry and Cytochemistry, vol. 38, no. 6, pp. 829–836, 1990. View at Scopus
  20. M. Adamo, M. K. Raizada, and D. LeRoith, “Insulin and insulin-like growth factor receptors in the nervous system,” Molecular Neurobiology, vol. 3, no. 1-2, pp. 71–100, 1989. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Schechter, L. Holtzclaw, F. Sadiq, A. Kahn, and S. Devaskar, “Insulin synthesis by isolated rabbit neurons,” Endocrinology, vol. 123, no. 1, pp. 505–513, 1988. View at Scopus
  22. J. Havrankova, J. Roth, and M. J. Brownstein, “Concentrations of insulin and of insulin receptors in the brain are independent of peripheral insulin levels. Studies of obese and streptozotocin-treated rodents,” Journal of Clinical Investigation, vol. 64, no. 2, pp. 636–642, 1979. View at Scopus
  23. W. A. Banks and A. J. Kastin, “Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin,” Peptides, vol. 19, no. 5, pp. 883–889, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. D. W. Clarke, L. Mudd, and F. T. Boyd Jr., “Insulin is released from rat brain neuronal cells in culture,” Journal of Neurochemistry, vol. 47, no. 3, pp. 831–836, 1986.
  25. S. Hoyer, “Memory function and brain glucose metabolism,” Pharmacopsychiatry, vol. 36, no. 1, pp. S62–S67, 2003. View at Scopus
  26. J. Havrankova, J. Roth, and M. Brownstein, “Insulin receptors are widely distributed in the central nervous system of the rat,” Nature, vol. 272, no. 5656, pp. 827–829, 1978. View at Scopus
  27. L. Li and C. Hölscher, “Common pathological processes in Alzheimer disease and type 2 diabetes: a review,” Brain Research Reviews, vol. 56, no. 2, pp. 384–402, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Cardoso, M. S. Santos, R. Seiça, and P. I. Moreira, “Cortical and hippocampal mitochondria bioenergetics and oxidative status during hyperglycemia and/or insulin-induced hypoglycemia,” Biochimica et Biophysica Acta, vol. 1802, no. 11, pp. 942–951, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. G. A. Werther, A. Hogg, B. J. Oldfield et al., “Localization and characterization of insulin receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry,” Endocrinology, vol. 121, no. 4, pp. 1562–1570, 1987. View at Scopus
  30. S. M. De La Monte and J. R. Wands, “Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 7, no. 1, pp. 45–61, 2005. View at Scopus
  31. W. Q. Zhao, H. Chen, M. J. Quon, and D. L. Alkon, “Insulin and the insulin receptor in experimental models of learning and memory,” European Journal of Pharmacology, vol. 490, no. 1–3, pp. 71–81, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. D. G. Baskin, A. J. Sipols, M. W. Schwartz, and M. F. White, “Immunocytochemical detection of insulin receptor substrate-1 (IRS-1) in rat brain: colocalization with phosphotyrosine,” Regulatory Peptides, vol. 48, no. 1-2, pp. 257–266, 1993. View at Publisher · View at Google Scholar · View at Scopus
  33. M. W. Schwartz, D. P. Figlewicz, D. G. Baskin, S. C. Woods, and D. Porte, “Insulin in the brain: a hormonal regulator of energy balance,” Endocrine Reviews, vol. 13, no. 3, pp. 387–414, 1992. View at Publisher · View at Google Scholar · View at Scopus
  34. J. L. Marks, M. G. King, and D. G. Baskin, “Insulin and insulin-like growth factors,” in Molecular Biology and Physiology of Insulin and Insulin-like Growth Factors, pp. 459–470, Plenum Press, New York, NY, USA, 1991.
  35. J. W. Unger, A. M. Moss, and J. N. Livingston, “Immunohistochemical localization of insulin receptors and phosphotyrosine in the brainstem of the adult rat,” Neuroscience, vol. 42, no. 3, pp. 853–861, 1991. View at Publisher · View at Google Scholar · View at Scopus
  36. J. L. Marks, J. Maddison, and C. J. Eastman, “Subcellular localization of rat brain insulin binding sites,” Journal of Neurochemistry, vol. 50, no. 3, pp. 774–781, 1988. View at Scopus
  37. L. M. Garcia-Segura, J. R. Rodriguez, and I. Torres-Aleman, “Localization of the insulin-like growth factor I receptor in the cerebellum and hypothalamus of adult rats: an electron microscopic study,” Journal of Neurocytology, vol. 26, no. 7, pp. 479–490, 1997. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Schlessinger, “Cell signaling by receptor tyrosine kinases,” Cell, vol. 103, no. 2, pp. 211–225, 2000. View at Scopus
  39. A. Wada, H. Yokoo, T. Yanagita, and H. Kobayashi, “New twist on neuronal insulin receptor signaling in health, disease, and therapeutics,” Journal of Pharmacological Sciences, vol. 99, no. 2, pp. 128–143, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. A. M. Moloney, R. J. Griffin, S. Timmons, R. O'Connor, R. Ravid, and C. O'Neill, “Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling,” Neurobiology of Aging, vol. 31, no. 2, pp. 224–243, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. N. R. Zahniser, M. B. Goens, P. J. Hanaway, and J. V. Vinych, “Characterization and regulation of insulin receptors in rat brain,” Journal of Neurochemistry, vol. 42, no. 5, pp. 1354–1362, 1984. View at Scopus
  42. F. T. Boyd and M. K. Raizada, “Effects of insulin and tunicamycin on neuronal insulin receptors in culture,” The American Journal of Physiology, vol. 245, no. 3, pp. C283–287, 1983. View at Scopus
  43. R. Conejo and M. Lorenzo, “Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts,” Journal of Cellular Physiology, vol. 187, no. 1, pp. 96–108, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. G. M. Cole and S. A. Frautschy, “The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's Disease,” Experimental Gerontology, vol. 42, no. 1-2, pp. 10–21, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Plum, B. F. Belgardt, and J. C. Brüning, “Central insulin action in energy and glucose homeostasis,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1761–1766, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. L. P. van der Heide, G. M. J. Ramakers, and M. P. Smidt, “Insulin signaling in the central nervous system: learning to survive,” Progress in Neurobiology, vol. 79, no. 4, pp. 205–221, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. M. D. Bruss, E. B. Arias, G. E. Lienhard, and G. D. Cartee, “Increased phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity,” Diabetes, vol. 54, no. 1, pp. 41–50, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. K. D. Niswender and M. W. Schwartz, “Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities,” Frontiers in Neuroendocrinology, vol. 24, no. 1, pp. 1–10, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. Z. C. Zhao, F. Li, and K. Maiese, “Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease,” Progress in Neurobiology, vol. 75, no. 3, pp. 207–246, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. K. G. Brywe, C. Mallard, M. Gustavsson et al., “IGF-I neuroprotection in the immature brain after hypoxia-ischemia, involvement of Akt and GSK3β?” European Journal of Neuroscience, vol. 21, no. 6, pp. 1489–1502, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Srinivasan, M. Ohsugi, Z. Liu, S. Fatrai, E. Bernal-Mizrachi, and M. A. Permutt, “Endoplasmic reticulum stress-induced apoptosis is partly mediated by reduced insulin signaling through phosphatidylinositol 3-kinase/Akt and increased glycogen synthase kinase-3β in mouse insulinoma cells,” Diabetes, vol. 54, no. 4, pp. 968–975, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Ogata, S. Iijima, S. Hoshikawa et al., “Opposing extracellular signal-regulated kinase and Akt pathways control schwann cell myelination,” Journal of Neuroscience, vol. 24, no. 30, pp. 6724–6732, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. N. Ibrahim, M. A. Bosch, J. L. Smart et al., “Hypothalamic proopiomelanocortin neurons are glucose responsive and express KATP channels,” Endocrinology, vol. 144, no. 4, pp. 1331–1340, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. X. Fang, S. X. Yu, Y. Lu, R. C. Bast, J. R. Woodgett, and G. B. Mills, “Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 22, pp. 11960–11965, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. N. Goode, K. Hughes, J. R. Woodgett, and P. J. Parker, “Differential regulation of glycogen synthase kinase-3β by protein kinase C isotypes,” Journal of Biological Chemistry, vol. 267, no. 24, pp. 16878–16882, 1992. View at Scopus
  56. R. S. Jope and G. V. W. Johnson, “The glamour and gloom of glycogen synthase kinase-3,” Trends in Biochemical Sciences, vol. 29, no. 2, pp. 95–102, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. Z. Sui, A. D. Kovács, and S. B. Maggirwar, “Recruitment of active glycogen synthase kinase-3 into neuronal lipid rafts,” Biochemical and Biophysical Research Communications, vol. 345, no. 4, pp. 1643–1648, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. J. A. Hartigan and G. V. W. Johnson, “Transient increases in intracellular calcium result in prolonged site-selective increases in Tau phosphorylation through a glycogen synthase kinase 3β-dependent pathway,” Journal of Biological Chemistry, vol. 274, no. 30, pp. 21395–21401, 1999. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Lesort, R. S. Jope, and G. V. W. Johnson, “Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3β and Fyn tyrosine kinase,” Journal of Neurochemistry, vol. 72, no. 2, pp. 576–584, 1999. View at Publisher · View at Google Scholar · View at Scopus
  60. J. F. Sanchez, L. F. Sniderhan, A. L. Williamson, S. Fan, S. Chakraborty-Sett, and S. B. Maggirwar, “Glycogen synthase kinase 3β-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor κB signaling,” Molecular and Cellular Biology, vol. 23, no. 13, pp. 4649–4662, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Pap and G. M. Cooper, “Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway,” Journal of Biological Chemistry, vol. 273, no. 32, pp. 19929–19932, 1998. View at Publisher · View at Google Scholar · View at Scopus
  62. R. J. Crowder and R. S. Freeman, “Glycogen synthase kinase-3β activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal,” Journal of Biological Chemistry, vol. 275, no. 44, pp. 34266–34271, 2000. View at Scopus
  63. H. J. Lin, X. Wang, K. M. Shaffer, C. Y. Sasaki, and W. Ma, “Characterization of H2O2-induced acute apoptosis in cultured neural stem/progenitor cells,” FEBS Letters, vol. 570, no. 1–3, pp. 102–106, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. A. I. Duarte, P. Santos, C. R. Oliveira, M. S. Santos, and A. C. Rego, “Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3β signaling pathways and changes in protein expression,” Biochimica et Biophysica Acta, vol. 1783, no. 6, pp. 994–1002, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. C. A. Grimes and R. S. Jope, “Creb DNA binding activity is inhibited by glycogen synthase kinase-3β and facilitated by lithium,” Journal of Neurochemistry, vol. 78, no. 6, pp. 1219–1232, 2001. View at Publisher · View at Google Scholar · View at Scopus
  66. S. Pugazhenthit, A. Nesterova, C. Sable et al., “Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein,” Journal of Biological Chemistry, vol. 275, no. 15, pp. 10761–10766, 2000. View at Publisher · View at Google Scholar · View at Scopus
  67. B. McLaughlin, K. A. Hartnett, J. A. Erhardt et al., “Caspase 3 activation is essential for neuroprotection in preconditioning,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 2, pp. 715–720, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. X. Zhu, A. K. Raina, H. G. Lee et al., “Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathways,” Antioxidants and Redox Signaling, vol. 5, no. 5, pp. 571–576, 2003. View at Scopus
  69. R. Wang, H. Y. Zhang, and X. C. Tang, “Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by β-amyloid protein-(1–40) in rat,” European Journal of Pharmacology, vol. 421, no. 3, pp. 149–156, 2001. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. Cheng, M. Deshmukh, A. D'Costa et al., “Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury,” Journal of Clinical Investigation, vol. 101, no. 9, pp. 1992–1999, 1998. View at Scopus
  71. C. P. Beier, J. Wischhusen, M. Gleichmann et al., “FasL (CD95L/APO-1L) resistance of neurons mediated by phosphatidylinositol 3-kinase-Akt/protein kinase B-dependent expression of lifeguard/neuronal membrane protein 35,” Journal of Neuroscience, vol. 25, no. 29, pp. 6765–6774, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. W. H. Zheng, S. Kar, and R. Quirion, “Insulin-like growth factor-1-induced phosphorylation of transcription factor FKHRL1 is mediated by phosphatidylinositol 3-kinase/Akt kinase and role of this pathway in insulin-like growth factor-1-induced survival of cultured hippocampal neurons,” Molecular Pharmacology, vol. 62, no. 2, pp. 225–233, 2002. View at Publisher · View at Google Scholar · View at Scopus
  73. D. A. Linseman, R. A. Phelps, R. J. Bouchard et al., “Insulin-like growth factor-I blocks Bcl-2 interacting mediator of cell death (Bim) induction and intrinsic death signaling in cerebellar granule neurons,” Journal of Neuroscience, vol. 22, no. 21, pp. 9287–9297, 2002. View at Scopus
  74. A. S. Baldwin, “The NF-κB and IκB proteins: new discoveries and insights,” Annual Review of Immunology, vol. 14, pp. 649–681, 1996. View at Scopus
  75. I. M. Verma, J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto, “Rel/NF-κB/IκB family: intimate tales of association and dissociation,” Genes and Development, vol. 9, no. 22, pp. 2723–2735, 1995. View at Scopus
  76. G. Chen, K. A. Bower, C. Ma, S. Fang, C. J. Thiele, and J. Luo, “Glycogen synthase kinase 3β (GSK3β) mediates 6-hydroxydopamine-induced neuronal death,” FASEB Journal, vol. 18, no. 10, pp. 1162–1164, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. A. I. Rojo, M. Salinas, D. Martín, R. Perona, and A. Cuadrado, “Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-κB,” Journal of Neuroscience, vol. 24, no. 33, pp. 7324–7334, 2004. View at Publisher · View at Google Scholar · View at Scopus
  78. S. M. Cardoso and C. R. Oliveira, “Glutathione cycle impairment mediates Aβ-induced cell toxicity,” Free Radical Research, vol. 37, no. 3, pp. 241–250, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. F. Li, C. Szabó, P. Pacher et al., “Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy,” Diabetologia, vol. 47, no. 4, pp. 710–717, 2004. View at Publisher · View at Google Scholar · View at Scopus
  80. T. J. Huang, A. Verkhratsky, and P. Fernyhough, “Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons,” Molecular and Cellular Neuroscience, vol. 28, no. 1, pp. 42–54, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. I. G. Onyango, J. P. Bennett, and J. B. Tuttle, “Endogenous oxidative stress in sporadic Alzheimer's disease neuronal cybrids reduces viability by increasing apoptosis through pro-death signaling pathways and is mimicked by oxidant exposure of control cybrids,” Neurobiology of Disease, vol. 19, no. 1-2, pp. 312–322, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. D. J. Levinthal and D. B. DeFranco, “Transient phosphatidylinositol 3-kinase inhibition protects immature primary cortical neurons from oxidative toxicity via suppression of extracellular signal-regulated kinase activation,” Journal of Biological Chemistry, vol. 279, no. 12, pp. 11206–11213, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. M. P. Mattson, S. Maudsley, and B. Martin, “A neural signaling triumvirate that influences ageing and age-related disease: insulin/IGF-1, BDNF and serotonin,” Ageing Research Reviews, vol. 3, no. 4, pp. 445–464, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. N. N. Johnson-Farley, T. Travkina, and D. S. Cowen, “Cumulative activation of Akt and consequent inhibition of glycogen synthase kinase-3 by brain-derived neurotrophic factor and insulin-like growth factor-1 in cultured hippocampal neurons,” Journal of Pharmacology and Experimental Therapeutics, vol. 316, no. 3, pp. 1062–1069, 2006. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Hetman, K. Kanning, J. E. Cavanaugh, and Z. Xia, “Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase,” Journal of Biological Chemistry, vol. 274, no. 32, pp. 22569–22580, 1999. View at Publisher · View at Google Scholar · View at Scopus
  86. J. D. Sweatt, “Mitogen-activated protein kinases in synaptic plasticity and memory,” Current Opinion in Neurobiology, vol. 14, no. 3, pp. 311–317, 2004. View at Publisher · View at Google Scholar · View at Scopus
  87. J. J. Haddad, “N-methyl-D-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signaling pathways: a revolving neurochemical axis for therapeutic intervention?” Progress in Neurobiology, vol. 77, no. 4, pp. 252–282, 2005. View at Publisher · View at Google Scholar · View at Scopus
  88. S. Subramaniam, N. Shahani, J. Strelau et al., “Insulin-like growth factor 1 inhibits extracellular signal-regulated kinase to promote neuronal survival via the phosphatidylinositol 3-kinase/protein kinase A/c-Raf pathway,” Journal of Neuroscience, vol. 25, no. 11, pp. 2838–2852, 2005. View at Publisher · View at Google Scholar · View at Scopus
  89. J. David Sweatt, “The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory,” Journal of Neurochemistry, vol. 76, no. 1, pp. 1–10, 2001. View at Publisher · View at Google Scholar · View at Scopus
  90. T. Purves, A. Middlemas, S. Agthong et al., “A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy,” FASEB Journal, vol. 15, no. 13, pp. 2508–2514, 2001. View at Publisher · View at Google Scholar · View at Scopus
  91. P. H. Groop, C. Forsblom, and M. C. Thomas, “Mechanisms of disease: pathway-selective insulin resistance and microvascular complications of diabetes,” Nature Clinical Practice, vol. 1, no. 2, pp. 100–110, 2005. View at Publisher · View at Google Scholar
  92. M. Maier, T. J. Seabrook, and C. A. Lemere, “Developing novel immunogens for an effective, safe Alzheimer's disease vaccine,” Neurodegenerative Diseases, vol. 2, no. 5, pp. 267–272, 2005. View at Publisher · View at Google Scholar · View at Scopus
  93. A. J. Barber, M. Nakamura, E. B. Wolpert et al., “Insulin rescues retinal neurons from apoptosis by a phosphatidylinositol 3-Kinase/Akt-mediated mechanism that reduces the activation of caspase-3,” Journal of Biological Chemistry, vol. 276, no. 35, pp. 32814–32821, 2001. View at Publisher · View at Google Scholar · View at Scopus
  94. R. T. Watson and J. E. Pessin, “Intracellular organization of insulin signaling and GLUT4 translocation,” Recent Progress in Hormone Research, vol. 56, pp. 175–193, 2001. View at Publisher · View at Google Scholar · View at Scopus
  95. S. Kang, J. Song, H. Kang, S. Kim, Y. Lee, and D. Park, “Insulin can block apoptosis by decreasing oxidative stress via phosphatidylinositol 3-kinase- and extracellular signal-regulated protein kinase-dependent signaling pathways in HepG2 cells,” European Journal of Endocrinology, vol. 148, no. 1, pp. 147–155, 2003. View at Publisher · View at Google Scholar · View at Scopus
  96. M. K. Barthwal, P. Sathyanarayana, C. N. Kundu et al., “Negative regulation of mixed lineage kinase 3 by protein kinase B/AKT leads to cell survival,” Journal of Biological Chemistry, vol. 278, no. 6, pp. 3897–3902, 2003. View at Publisher · View at Google Scholar · View at Scopus
  97. Y. Okubo, V. A. Blakesley, B. Stannard, S. Gutkind, and D. L. Roith, “Insulin-like growth factor-I inhibits the stress-activated protein kinase/c-Jun N-terminal kinase,” Journal of Biological Chemistry, vol. 273, no. 40, pp. 25961–25966, 1998. View at Publisher · View at Google Scholar · View at Scopus
  98. P. C. Geiger, D. C. Wright, D.-H. Han, and J. O. Holloszy, “Activation of p38 MAP kinase enhances sensitivity of muscle glucose transport to insulin,” American Journal of Physiology, vol. 288, no. 4, pp. E782–E788, 2005. View at Publisher · View at Google Scholar
  99. R. Somwar, S. Koterski, G. Sweeney et al., “A dominant-negative p38 MAPK mutant and novel selective inhibitors of p38 MAPK reduce insulin-stimulated glucose uptake in 3T3-L1 adipocytes without affecting GLUT4 translocation,” Journal of Biological Chemistry, vol. 277, no. 52, pp. 50386–50395, 2002. View at Publisher · View at Google Scholar · View at Scopus
  100. D. Konrad, R. Somwar, G. Sweeney et al., “The antihyperglycemic drug α-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation,” Diabetes, vol. 50, no. 6, pp. 1464–1471, 2001. View at Scopus
  101. R. Somwar, M. Perreault, S. Kapur et al., “Activation of p38 mitogen-activated protein kinase α and β by insulin and contraction in rat skeletal muscle: potential role in the stimulation of glucose transport,” Diabetes, vol. 49, no. 11, pp. 1794–1800, 2000. View at Scopus
  102. G. Sweeney, R. Somwar, T. Ramlal, A. Volchuk, A. Ueyama, and A. Klip, “An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes,” Journal of Biological Chemistry, vol. 274, no. 15, pp. 10071–10078, 1999. View at Publisher · View at Google Scholar · View at Scopus
  103. S. K. Kim, K. J. Woodcroft, and R. F. Novak, “Insulin and glucagon regulation of glutathione S-transferase expression in primary cultured rat hepatocytes,” Journal of Pharmacology and Experimental Therapeutics, vol. 305, no. 1, pp. 353–361, 2003. View at Publisher · View at Google Scholar · View at Scopus
  104. G. M. Leinninger, C. Backus, M. D. Uhler, S. I. Lentz, and E. L. Feldman, “Phosphatidylinositol 3-kinase and Akt effectors mediate insulin-like growth factor-I neuroprotection in dorsal root ganglia neurons,” FASEB Journal, vol. 18, no. 13, pp. 1544–1546, 2004. View at Publisher · View at Google Scholar · View at Scopus
  105. L. Gasparini and H. Xu, “Potential roles of insulin and IGF-1 in Alzheimer's disease,” Trends in Neurosciences, vol. 26, no. 8, pp. 404–406, 2003. View at Publisher · View at Google Scholar · View at Scopus
  106. M. S. Santos, E. M. Pereira, and A. P. Carvaho, “Stimulation of immunoreactive insulin release by glucose in rat brain synaptosomes,” Neurochemical Research, vol. 24, no. 1, pp. 33–36, 1999. View at Publisher · View at Google Scholar · View at Scopus
  107. B. H. Shah and R. E. Hausman, “Effect of insulin on GABAergic development in the embryonic chick retina,” Developmental Brain Research, vol. 72, no. 2, pp. 151–158, 1993. View at Publisher · View at Google Scholar · View at Scopus
  108. J. W. Yang, M. K. Raizada, and R. E. Fellows, “Effects of insulin on cultured rat brain cells: stimulation of ornithine decarboxylase activity,” Journal of Neurochemistry, vol. 36, no. 3, pp. 1050–1057, 1981. View at Scopus
  109. D. Plitzko, S. Rumpel, and K. Gottmann, “Insulin promotes functional induction of silent synapses in differentiating rat neocortical neurons,” European Journal of Neuroscience, vol. 14, no. 8, pp. 1412–1415, 2001. View at Publisher · View at Google Scholar
  110. J. Kremerskothen, D. Wendholt, I. Teber, and A. Barnekow, “Insulin-induced expression of the activity-regulated cytoskeleton-associated gene (ARC) in human neuroblastoma cells requires p21ras, mitogen-activated protein kinase/extracellular regulated kinase and src tyrosine kinases but is protein kinase C-independent,” Neuroscience Letters, vol. 321, no. 3, pp. 153–156, 2002. View at Publisher · View at Google Scholar · View at Scopus
  111. C. Vilchis and R. Salceda, “Effect of diabetes on levels and uptake of putative amino acid neurotransmitters in rat retina and retinal pigment epithelium,” Neurochemical Research, vol. 21, no. 10, pp. 1167–1171, 1996. View at Publisher · View at Google Scholar · View at Scopus
  112. A. Shuaib, M. S. Ijaz, T. Waqar et al., “Insulin elevates hippocampal GABA levels during ischemia. This is independent of its hypoglycemic effect,” Neuroscience, vol. 67, no. 4, pp. 809–814, 1995. View at Publisher · View at Google Scholar · View at Scopus
  113. B. E. Levin, “Factors promoting and ameliorating the development of obesity,” Physiology and Behavior, vol. 86, no. 5, pp. 633–639, 2005. View at Publisher · View at Google Scholar
  114. J. L. Sievenpiper, A. L. Jenkins, D. L. Whitham, and V. Vuksan, “Insulin resistance: concepts, controversies, and the role of nutrition,” Canadian Journal of Dietetic Practice and Research, vol. 63, no. 1, pp. 20–32, 2002. View at Scopus
  115. D. Porte, D. G. Baskin, and M. W. Schwartz, “Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans,” Diabetes, vol. 54, no. 5, pp. 1264–1276, 2005. View at Publisher · View at Google Scholar · View at Scopus
  116. B. E. Levin, “Metabolic sensing neurons and the control of energy homeostasis,” Physiology and Behavior, vol. 89, no. 4, pp. 486–489, 2006. View at Publisher · View at Google Scholar · View at Scopus
  117. G. J. Morton, D. E. Cummings, D. G. Baskin, G. S. Barsh, and M. W. Schwartz, “Central nervous system control of food intake and body weight,” Nature, vol. 443, no. 7109, pp. 289–295, 2006. View at Publisher · View at Google Scholar · View at Scopus
  118. J. Girard, “The inhibitory effects of insulin on hepatic glucose production are both direct and indirect,” Diabetes, vol. 55, no. 2, pp. S65–S69, 2006. View at Publisher · View at Google Scholar · View at Scopus
  119. S. Obici, Z. Feng, G. Karkanias, D. G. Baskin, and L. Rossetti, “Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats,” Nature Neuroscience, vol. 5, no. 6, pp. 566–572, 2002. View at Publisher · View at Google Scholar · View at Scopus
  120. A. L. McCall, “Cerebral glucose metabolism in diabetes mellitus,” European Journal of Pharmacology, vol. 490, no. 1–3, pp. 147–158, 2004. View at Publisher · View at Google Scholar · View at Scopus
  121. K. A. Heidenreich and D. Brandenburg, “Oligosaccharide heterogeneity of insulin receptors. Comparison of N-linked glycosylation of insulin receptors in adipocytes and brain,” Endocrinology, vol. 118, no. 5, pp. 1835–1842, 1986. View at Scopus
  122. D. W. Clarke, F. T. Boyd, M. S. Kappy, and K. Raizada, “Insulin binds to specific receptors and stimulates 2-deoxy-D-glucose uptake in cultured glial cells from rat brain,” Journal of Biological Chemistry, vol. 259, no. 19, pp. 11672–11675, 1984. View at Scopus
  123. S. Hoyer and L. Frölich, “Brain function and insulin signal transduction in sporadic Alzheimer’s disease,” in Research Progress in Alzheimer’s Disease and Dementia, M. Sich, Ed., pp. 23–46, Nova Science, New York, NY, USA, 2006.
  124. C. R. Park, “Cognitive effects of insulin in the central nervous system,” Neuroscience and Biobehavioral Reviews, vol. 25, no. 4, pp. 311–323, 2001. View at Publisher · View at Google Scholar · View at Scopus
  125. S. J. Vannucci, E. M. Koehler-Stec, K. Li, T. H. Reynolds, R. Clark, and I. A. Simpson, “GLUT4 glucose transporter expression in rodent brain: effect of diabetes,” Brain Research, vol. 797, no. 1, pp. 1–11, 1998. View at Publisher · View at Google Scholar · View at Scopus
  126. S. Craft and G. S. Watson, “Insulin and neurodegenerative disease: shared and specific mechanisms,” Lancet Neurology, vol. 3, no. 3, pp. 169–178, 2004. View at Publisher · View at Google Scholar · View at Scopus
  127. E. M. Bingham, D. Hopkins, D. Smith et al., “The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study,” Diabetes, vol. 51, no. 12, pp. 3384–3390, 2002. View at Scopus
  128. A. Ghosh, Y. C. Yuk, B. C. Mansfield, and J. Y. Chou, “Brain contains a functional glucose-6-phosphatase complex capable of endogenous glucose production,” Journal of Biological Chemistry, vol. 280, no. 12, pp. 11114–11119, 2005. View at Publisher · View at Google Scholar · View at Scopus
  129. J. W. Russell, D. Golovoy, A. M. Vincent et al., “High glucose-induced oxidative stress and mitochondrial dysfunction in nuerons,” FASEB Journal, vol. 16, no. 13, pp. 1738–1748, 2002. View at Publisher · View at Google Scholar · View at Scopus
  130. X. Wu, C. E. N. Reiter, D. A. Antonetti, S. R. Kimball, L. S. Jefferson, and T. W. Gardner, “Insulin Promotes Rat Retinal Neuronal Cell Survival in a p70S6K-dependent Manner,” Journal of Biological Chemistry, vol. 279, no. 10, pp. 9167–9175, 2004. View at Publisher · View at Google Scholar · View at Scopus
  131. J. R. Koo and N. D. Vaziri, “Effects of diabetes, insulin and antioxidants on No synthase abundance and No interaction with reactive oxygen species,” Kidney International, vol. 63, no. 1, pp. 195–201, 2003. View at Publisher · View at Google Scholar · View at Scopus
  132. A. I. Duarte, T. Proença, C. R. Oliveira, M. S. Santos, and A. C. Rego, “Insulin restores metabolic function in cultured cortical neurons subjected to oxidative stress,” Diabetes, vol. 55, no. 10, pp. 2863–2870, 2006. View at Publisher · View at Google Scholar · View at Scopus
  133. U. Stockhorst, D. De Fries, H.-J. Steingrueber, and W. A. Scherbaum, “Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans,” Physiology and Behavior, vol. 83, no. 1, pp. 47–54, 2004. View at Publisher · View at Google Scholar
  134. E. R. Seaquist, G. S. Damberg, I. Tkac, and R. Gruetter, “The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans,” Diabetes, vol. 50, no. 10, pp. 2203–2209, 2001. View at Scopus
  135. S. G. Hasselbalch, G. M. Knudsen, C. Videbaek et al., “No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans,” Diabetes, vol. 48, no. 10, pp. 1915–1921, 1999. View at Publisher · View at Google Scholar · View at Scopus
  136. B. J. Dickson, “Wiring the brain with insulin,” Science, vol. 300, no. 5618, pp. 440–441, 2003. View at Publisher · View at Google Scholar · View at Scopus
  137. J. Song, L. Wu, Z. Chen, R. A. Kohanski, and L. Pick, “Axons guided by insulin receptor in Drosophila visual system,” Science, vol. 300, no. 5618, pp. 502–505, 2003. View at Publisher · View at Google Scholar · View at Scopus
  138. K. Sugimoto, M. Baba, T. Suda, M. Yasujima, and S. Yagihashi, “Peripheral neuropathy and microangiopathy in rats with insulinoma: association with chronic hyperinsulinemia,” Diabetes/Metabolism Research and Reviews, vol. 19, no. 5, pp. 392–400, 2003. View at Publisher · View at Google Scholar · View at Scopus
  139. I. Torres-Aleman, “Insulin-like growth factors as mediators of functional plasticity in the adult brain,” Hormone and Metabolic Research, vol. 31, no. 2-3, pp. 114–119, 1999. View at Scopus
  140. E. Recio-Pinto, M. M. Rechler, and D. N. Ishii, “Effects of insulin, insulin-like growth factor-II, and nerve growth factor on neurite formation and survival cultured sympathetic and sensory neurons,” Journal of Neuroscience, vol. 6, no. 5, pp. 1211–1219, 1986. View at Scopus
  141. H. Dudek, S. R. Datta, T. F. Franke et al., “Regulation of neuronal survival by the serine-threonine protein kinase Akt,” Science, vol. 275, no. 5300, pp. 661–665, 1997. View at Publisher · View at Google Scholar · View at Scopus
  142. M. Tanaka, M. Sawada, S. Yoshida, F. Hanaoka, and T. Marunouchi, “Insulin prevents apoptosis of external granular layer neurons in rat cerebellar slice cultures,” Neuroscience Letters, vol. 199, no. 1, pp. 37–40, 1995. View at Publisher · View at Google Scholar · View at Scopus
  143. T. Takadera, N. Sakura, T. Mohri, and T. Hashimoto, “Toxic effect of a beta-amyloid peptide (beta 22–35) on the hippocampa l neuron and its prevention,” Neuroscience Letters, vol. 14, pp. 41–44, 1993.
  144. C. Benedict, M. Hallschmid, A. Hatke et al., “Intranasal insulin improves memory in humans,” Psychoneuroendocrinology, vol. 29, no. 10, pp. 1326–1334, 2004. View at Publisher · View at Google Scholar · View at Scopus
  145. W. Kern, A. Peters, B. Fruehwald-Schultes, E. Deininger, J. Born, and H. L. Fehm, “Improving influence of insulin on cognitive functions in humans,” Neuroendocrinology, vol. 74, no. 4, pp. 270–280, 2001. View at Publisher · View at Google Scholar · View at Scopus
  146. F. T. Boyd, D. W. Clarke, and M. K. Raizada, “Insulin inhibits specific norepinephrine uptake in neuronal cultures from rat brain,” Brain Research, vol. 398, no. 1, pp. 1–5, 1986. View at Scopus
  147. M. L. Barbaccia, D. M. Chuang, and E. Costa, “Is insulin a neuromodulator?” Advances in Biochemical Psychopharmacology, vol. 33, pp. 511–518, 1982. View at Scopus
  148. A. Sauter, M. Goldstein, J. Engel, and K. Ueta, “Effect of insulin on central catecholamines,” Brain Research, vol. 260, no. 2, pp. 330–333, 1983. View at Publisher · View at Google Scholar · View at Scopus
  149. M. K. Raizada, J. Shemer, J. H. Judkins, D. W. Clarke, B. A. Masters, and D. LeRoith, “Insulin receptors in the brain: structural and physiological characterization,” Neurochemical Research, vol. 13, no. 4, pp. 297–303, 1988. View at Scopus
  150. B. A. Masters, J. Shemer, J. H. Judkins, D. W. Clarke, D. Le Roith, and M. K. Raizada, “Insulin receptors and insulin action in dissociated brain cells,” Brain Research, vol. 417, no. 2, pp. 247–256, 1987. View at Scopus
  151. E. M. Richards, M. K. Raizada, and C. Summers, “Insulin downregulates alpha-2 adrenergic receptors in cultured glial cells,” in Insulin, Insulin-Like Growth Factors and Their Receptors in the Central Nervous System, M. K. Raizada, M. I. Phillips, and D. Le Roith, Eds., p. 209, 1987.
  152. F. T. Boyd, D. W. Clarke, T. F. Muther, and M. K. Raizada, “Insulin receptors and insulin modulation of norepinephrine uptake in neuronal cultures from rat brain,” Journal of Biological Chemistry, vol. 260, no. 29, pp. 15880–15884, 1985. View at Scopus
  153. V. A. Skeberdis, J. Y. Lan, X. Zheng, R. S. Zukin, and M. V. L. Bennett, “Insulin promotes rapid delivery of N-methyl-D-aspartate receptors to the cell surface by exocytosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 6, pp. 3561–3566, 2001. View at Publisher · View at Google Scholar · View at Scopus
  154. L. P. Van Der Heide, A. Kamal, A. Artola, W. H. Gispen, and G. M. J. Ramakers, “Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-D-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner,” Journal of Neurochemistry, vol. 94, no. 4, pp. 1158–1166, 2005. View at Publisher · View at Google Scholar · View at Scopus
  155. A. I. Duarte, M. S. Santos, R. Seiça, and C. R. Oliveira, “Oxidative stress affects synaptosomal γ-aminobutyric acid and glutamate transport in diabetic rats: the role of insulin,” Diabetes, vol. 53, no. 8, pp. 2110–2116, 2004. View at Publisher · View at Google Scholar · View at Scopus
  156. A. I. Duarte, M. S. Santos, R. Seiça, and C. R. De Oliveira, “Insulin affects synaptosomal GABA and glutamate transport under oxidative stress conditions,” Brain Research, vol. 977, no. 1, pp. 23–30, 2003. View at Publisher · View at Google Scholar · View at Scopus
  157. A. I. Duarte, M. S. Santos, C. R. Oliveira, and A. C. Rego, “Insulin neuroprotection against oxidative stress in cortical neurons—involvement of uric acid and glutathione antioxidant defenses,” Free Radical Biology and Medicine, vol. 39, no. 7, pp. 876–889, 2005. View at Publisher · View at Google Scholar · View at Scopus
  158. W. Hamabe, R. Fujita, and H. Ueda, “Neuronal necrosis inhibition by insulin through protein kinase C activation,” Journal of Pharmacology and Experimental Therapeutics, vol. 307, no. 1, pp. 205–212, 2003. View at Publisher · View at Google Scholar · View at Scopus
  159. F. Hong, S. J. Kwon, B. S. Jhun et al., “Insulin-like growth factor-1 protects H9c2 cardiac myoblasts from oxidative stress-induced apoptosis via phosphatidylinositol 3-kinase and extracellular signal-regulated kinase pathways,” Life Sciences, vol. 68, no. 10, pp. 1095–1105, 2001. View at Publisher · View at Google Scholar · View at Scopus
  160. B. R. Ryu, H. W. Ko, I. Jou, J. S. Noh, and B. J. Gwag, “Phosphatidylinositol 3-kinase-mediated regulation of neuronal apoptosis and necrosis by insulin and IGF-I,” Journal of Neurobiology, vol. 39, no. 4, pp. 536–546, 1999. View at Publisher · View at Google Scholar · View at Scopus
  161. B. J. Gwag, J. Y. Koh, J. A. Demaro, H. S. Ying, M. Jacquin, and D. W. Choi, “Slowly triggered excitotoxicity occurs by necrosis in cortical cultures,” Neuroscience, vol. 77, no. 2, pp. 393–401, 1997. View at Publisher · View at Google Scholar · View at Scopus
  162. S. R. D'Mello, C. Galli, T. Ciotti, and P. Calissano, “Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 23, pp. 10989–10993, 1993. View at Publisher · View at Google Scholar · View at Scopus
  163. G. Kyriaki, “Brain insulin: regulation, mechanisms of action and functions,” Cellular and Molecular Neurobiology, vol. 23, no. 1, pp. 1–25, 2003. View at Publisher · View at Google Scholar · View at Scopus
  164. G. S. Watson and S. Craft, “The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment,” CNS Drugs, vol. 17, no. 1, pp. 27–45, 2003. View at Publisher · View at Google Scholar · View at Scopus
  165. P. C. Chin, N. Majdzadeh, and S. R. D'Mello, “Inhibition of GSK3β is a common event in neuroprotection by different survival factors,” Molecular Brain Research, vol. 137, no. 1-2, pp. 193–201, 2005. View at Publisher · View at Google Scholar · View at Scopus
  166. S. J. Kim and Y. Han, “Insulin inhibits AMPA-induced neuronal damage via stimulation of protein kinase B (Akt),” Journal of Neural Transmission, vol. 112, no. 2, pp. 179–191, 2005. View at Publisher · View at Google Scholar · View at Scopus
  167. M. Schubert, D. Gautam, D. Surjo et al., “Role for neuronal insulin resistance in neurodegenerative diseases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 9, pp. 3100–3105, 2004. View at Publisher · View at Google Scholar
  168. K. M. Noh, J. C. Lee, Y. H. Ahn, S. H. Hong, and J. Y. Koh, “Insulin-induced oxidative neuronal injury in cortical culture: mediation by induced N-methyl-D-aspartate receptors,” IUBMB Life, vol. 48, no. 3, pp. 263–269, 1999. View at Publisher · View at Google Scholar · View at Scopus
  169. World Health Organization, “Diabetes facts,” Fact sheet no. 312, 2011, http://www.who.int/mediacentre/factsheets/fs312/en/.
  170. T. Tuomi, “Type 1 and type 2 diabetes: what do they have in common?” Diabetes, vol. 54, supplement 2, pp. S40–S45, 2005. View at Publisher · View at Google Scholar · View at Scopus
  171. A. M. Vincent, L. L. McLean, C. Backus, and E. L. Feldman, “Short-term hyperglycemia produces oxidative damage and apoptosis in neurons,” FASEB Journal, vol. 19, no. 6, pp. 638–640, 2005. View at Publisher · View at Google Scholar · View at Scopus
  172. G. J. Biessels, L. P. Van der Heide, A. Kamal, R. L. A. W. Bleys, and W. H. Gispen, “Ageing and diabetes: implications for brain function,” European Journal of Pharmacology, vol. 441, no. 1-2, pp. 1–14, 2002. View at Publisher · View at Google Scholar · View at Scopus
  173. S. Craft, “Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation,” Neurobiology of Aging, vol. 26, supplement, pp. S65–S69, 2005. View at Publisher · View at Google Scholar
  174. M. Ristow, “Neurodegenetive disorders associated with diabetes mellitus,” Journal of Molecular Medicine, vol. 82, no. 8, pp. 510–529, 2004. View at Publisher · View at Google Scholar · View at Scopus
  175. G. S. Watson and S. Craft, “Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease,” European Journal of Pharmacology, vol. 490, no. 1–3, pp. 97–113, 2004. View at Publisher · View at Google Scholar · View at Scopus
  176. G. G. Piroli, C. A. Grillo, M. J. Charron, B. S. McEwen, and L. P. Reagan, “Biphasic effects of stress upon GLUT8 glucose transporter expression and trafficking in the diabetic rat hippocampus,” Brain Research, vol. 1006, no. 1, pp. 28–35, 2004. View at Publisher · View at Google Scholar · View at Scopus
  177. M. S. Santos, A. I. Duarte, M. J. Matos, T. Proença, R. Seiça, and C. R. Oliveira, “Synaptosomes isolated from Goto-Kakizaki diabetic rat brain exhibit increased resistance to oxidative stress: role of vitamin E,” Life Sciences, vol. 67, no. 25, pp. 3061–3073, 2000. View at Scopus
  178. P. I. Moreira, M. S. Santos, A. M. Moreno, R. Seiça, and C. R. Oliveira, “Increased vulnerability of brain mitochondria in diabetic (goto-kakizaki) rats with aging and amyloid-β exposure,” Diabetes, vol. 52, no. 6, pp. 1449–1456, 2003. View at Publisher · View at Google Scholar · View at Scopus
  179. P. I. Moreira, M. S. Santos, C. Sena, E. Nunes, R. Seiça, and C. R. Oliveira, “CoQ10 therapy attenuates amyloid β-peptide toxicity in brain mitochondria isolated from aged diabetic rats,” Experimental Neurology, vol. 196, no. 1, pp. 112–119, 2005. View at Publisher · View at Google Scholar
  180. P. I. Moreira, M. S. Santos, C. Sena, R. Seiça, and C. R. Oliveira, “Insulin protects against amyloid β-peptide toxicity in brain mitochondria of diabetic rats,” Neurobiology of Disease, vol. 18, no. 3, pp. 628–637, 2005. View at Publisher · View at Google Scholar
  181. S. Correia, C. Carvalho, M. S. Santos et al., “Metformin protects the brain against the oxidative imbalance promoted by type 2 diabetes,” Medicinal Chemistry, vol. 4, no. 4, pp. 358–364, 2008. View at Publisher · View at Google Scholar · View at Scopus
  182. R. Mastrocola, F. Restivo, I. Vercellinatto et al., “Oxidative and nitrosative stress in brain mitochondria of diabetic rats,” Journal of Endocrinology, vol. 187, no. 1, pp. 37–44, 2005. View at Publisher · View at Google Scholar · View at Scopus
  183. Z. G. Li, W. Zhang, and A. A. F. Sima, “The role of impaired insulin/IGF action in primary diabetic encephalopathy,” Brain Research, vol. 1037, no. 1-2, pp. 12–24, 2005. View at Publisher · View at Google Scholar · View at Scopus
  184. S. Correia, C. Carvalho, M. S. Santos, R. Seiça, C. R. Oliveira, and P. I. Moreira, “Mechanisms of action of metformin in type 2 diabetes and associated complications: an overview,” Mini reviews in Medicinal Chemistry, vol. 8, no. 13, pp. 1343–1354, 2008. View at Publisher · View at Google Scholar · View at Scopus
  185. I. G. Obrosova, V. R. Drel, P. Pacher et al., “Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited,” Diabetes, vol. 54, no. 12, pp. 3435–3441, 2005. View at Publisher · View at Google Scholar · View at Scopus
  186. L. L. Guyot, F. G. Diaz, M. H. O'Regan, D. Song, and J. W. Phillis, “The effect of topical insulin on the release of excitotoxic and other amino acids from the rat cerebral cortex during streptozotocin-induced hyperglycemic ischemia,” Brain Research, vol. 872, no. 1-2, pp. 29–36, 2000. View at Publisher · View at Google Scholar · View at Scopus
  187. L. L. Guyot, F. G. Diaz, M. H. O'Regan, D. Song, and J. W. Phillis, “Topical insulin and accumulation of excitotoxic and other amino acids in ischemic rat cerebral cortex,” Experimental Biology and Medicine, vol. 224, no. 1, pp. 28–31, 2000. View at Scopus
  188. J. W. Phillis, D. Song, and M. H. O'Regan, “Effect of hyperglycemia on extracellular levels of amino acids and free fatty acids in the ischemic/reperfused rat cerebral cortex,” Brain Research, vol. 837, no. 1-2, pp. 177–183, 1999. View at Publisher · View at Google Scholar · View at Scopus
  189. S. Cardoso, C. Carvalho, R. Santos et al., “Impact of STZ-induced hyperglycemia and insulin-induced hypoglycemia in plasma amino acids and cortical synaptosomal neurotransmitters,” Synapse, vol. 65, no. 6, pp. 457–466, 2011. View at Publisher · View at Google Scholar
  190. W. A. Hsueh, L. M. Moore, and M. Bryer-Ash, “Pathophysiology of type 2 diabetes: a quartet of abnormalities,” in Contemporary Diagnosis and Management of Type 2 Diabetes, W. A. Hsueh, L. M. Moore, and M. Bryer-Ash, Eds., pp. 5–19, Handbooks in Health Care, Newtown, Pa, USA, 2nd edition, 2004.
  191. J. Buse, “Combining insulin and oral agents,” American Journal of Medicine, vol. 108, no. supplement 6, pp. 23–32, 2000. View at Scopus
  192. R. C. Turner, C. A. Cull, V. Frighi, and R. R. Holman, “Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. Progressive requirement for multiple therapies (UKPDS 49),” Journal of the American Medical Association, vol. 281, no. 21, pp. 2005–2012, 1999. View at Publisher · View at Google Scholar
  193. P. Singh, A. Jain, and G. Kaur, “Impact of hypoglycemia and diabetes on CNS: correlation of mitochondrial oxidative stress with DNA damage,” Molecular and Cellular Biochemistry, vol. 260, no. 1, pp. 153–159, 2004. View at Publisher · View at Google Scholar · View at Scopus
  194. P. I. Moreira, A. P. Rolo, C. Sena, R. Seiça, C. R. Oliveira, and M. S. Santos, “Insulin attenuates diabetes-related mitochondrial alterations: a comparative study,” Medicinal Chemistry, vol. 2, no. 3, pp. 299–308, 2006. View at Publisher · View at Google Scholar · View at Scopus
  195. G. J. Biessels and W. H. Gispen, “The impact of diabetes on cognition: what can be learned from rodent models?” Neurobiology of Aging, vol. 26, supplement, pp. S36–S41, 2005. View at Publisher · View at Google Scholar · View at Scopus
  196. M. Brownlee, “Biochemistry and molecular cell biology of diabetic complications,” Nature, vol. 414, no. 6865, pp. 813–820, 2001. View at Publisher · View at Google Scholar · View at Scopus
  197. N. N. Rizk, J. Rafols, and J. C. Dunbar, “Cerebral ischemia induced apoptosis and necrosis in normal and diabetic rats,” Brain Research, vol. 1053, no. 1-2, pp. 1–9, 2005. View at Publisher · View at Google Scholar · View at Scopus
  198. Y. Soeda, H. Tsuneki, H. Muranaka et al., “The inositol phosphatase SHIP2 negatively regulates insulin/IGF-I actions implicated in neuroprotection and memory function in mouse brain,” Molecular Endocrinology, vol. 24, no. 10, pp. 1965–1977, 2010. View at Publisher · View at Google Scholar · View at Scopus
  199. W. H. Gispen and G. J. Biessels, “Cognition and synaptic plasticity in diabetes mellitus,” Trends in Neurosciences, vol. 23, no. 11, pp. 542–549, 2000. View at Publisher · View at Google Scholar · View at Scopus
  200. L. Gasparini, W. J. Netzer, P. Greengard, and H. Xu, “Does insulin dysfunction play a role in Alzheimer's disease?” Trends in Pharmacological Sciences, vol. 23, no. 6, pp. 288–293, 2002. View at Publisher · View at Google Scholar · View at Scopus
  201. V. Brussee, F. A. Cunningham, and D. W. Zochodne, “Direct insulin signalling of neurons reverses diabetic neuropathy,” Diabetes, vol. 53, no. 7, pp. 1824–1830, 2004. View at Publisher · View at Google Scholar · View at Scopus
  202. J. Vijg and Y. Suh, “Genetics of longevity and aging,” Annual Review of Medicine, vol. 56, pp. 193–212, 2005. View at Publisher · View at Google Scholar
  203. R. A. Miller, “Cell stress and aging: new emphasis on multiplex resistance mechanisms,” Journals of Gerontology A, vol. 64, no. 2, pp. 179–182, 2009. View at Publisher · View at Google Scholar
  204. D. Harman, “Free radical theory of aging: effect of free radical reaction inhibitors on the mortality rate of male LAF mice,” Journals of Gerontology, vol. 23, no. 4, pp. 476–482, 1968.
  205. G. J. Brewer, “Epigenetic oxidative redox shift (EORS) theory of aging unifies the free radical and insulin signaling theories,” Experimental Gerontology, vol. 45, no. 3, pp. 173–179, 2010. View at Publisher · View at Google Scholar · View at Scopus
  206. E. R. Miller, R. Pastor-Barriuso, D. Dalal, R. A. Riemersma, L. J. Appel, and E. Guallar, “Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality,” Annals of Internal Medicine, vol. 142, no. 1, pp. 37–46, 2005. View at Scopus
  207. G. Bjelakovic, D. Nikolova, L. L. Gluud, R. G. Simonetti, and C. Gluud, “Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis,” Journal of the American Medical Association, vol. 297, no. 8, pp. 842–857, 2007. View at Publisher · View at Google Scholar · View at Scopus
  208. V. I. Pérez, H. Van Remmen, A. Bokov, C. J. Epstein, J. Vijg, and A. Richardson, “The overexpression of major antioxidant enzymes does not extend the lifespan of mice,” Aging Cell, vol. 8, no. 1, pp. 73–75, 2009. View at Publisher · View at Google Scholar · View at Scopus
  209. A. Mitsui, J. Hamuro, H. Nakamura et al., “Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span,” Antioxidants and Redox Signaling, vol. 4, no. 4, pp. 693–696, 2002. View at Scopus
  210. S. E. Schriner, N. J. Linford, G. M. Martin et al., “Medecine: extension of murine life span by overexpression of catalase targeted to mitochondria,” Science, vol. 308, no. 5730, pp. 1909–1911, 2005. View at Publisher · View at Google Scholar · View at Scopus
  211. R. Weindruch, T. Kayo, C. K. Lee, and T. A. Prolla, “Microarray profiling of gene expression in aging and its alteration by caloric restriction in mice,” Journal of Nutrition, vol. 131, no. 3, pp. 918S–923S, 2001. View at Scopus
  212. C. S. Carter, M. M. Ramsey, and W. E. Sonntag, “A critical analysis of the role of growth hormone and IGF-1 in aging and lifespan,” Trends in Genetics, vol. 18, no. 6, pp. 295–301, 2002. View at Publisher · View at Google Scholar · View at Scopus
  213. L. K. Heilbronn, L. De Jonge, M. I. Frisard et al., “Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial,” Journal of the American Medical Association, vol. 295, no. 13, pp. 1539–1548, 2006. View at Publisher · View at Google Scholar · View at Scopus
  214. K. A. Al-Regaiey, M. M. Masternak, M. S. Bonkowski, J. A. Panici, J. J. Kopchick, and A. Bartke, “Effects of caloric restriction and growth hormone resistance on insulin-related intermediates in the skeletal muscle,” Journals of Gerontology A, vol. 62, no. 1, pp. 18–26, 2007. View at Scopus
  215. M. M. Masternak, K. A. Al-Regaiey, M. M. D. R. Lim et al., “Effects of caloric restriction on insulin pathway gene expression in the skeletal muscle and liver of normal and long-lived GHR-KO mice,” Experimental Gerontology, vol. 40, no. 8-9, pp. 679–684, 2005. View at Publisher · View at Google Scholar
  216. R. Westbrook, M. S. Bonkowski, A. D. Strader, and A. Bartke, “Alterations in oxygen consumption, respiratory quotient, and heat production in long-lived GHRKO and Ames dwarf mice, and short-lived bGH transgenic mice,” Journals of Gerontology A, vol. 64, no. 4, pp. 443–451, 2009. View at Publisher · View at Google Scholar · View at Scopus
  217. T. Kimura, J. Takamatsu, K. Ikeda, A. Kondo, T. Miyakawa, and S. Horiuchi, “Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons,” Neuroscience Letters, vol. 208, no. 1, pp. 53–56, 1996. View at Publisher · View at Google Scholar · View at Scopus
  218. L. Plum, M. Schubert, and J. C. Brüning, “The role of insulin receptor signaling in the brain,” Trends in Endocrinology and Metabolism, vol. 16, no. 2, pp. 59–65, 2005. View at Publisher · View at Google Scholar
  219. L. Frölich, D. Blum-Degen, H.-G. Bernstein et al., “Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease,” Journal of Neural Transmission, vol. 105, no. 4-5, pp. 423–438, 1998. View at Publisher · View at Google Scholar
  220. N. Potau, M. A. Escofet, and M. C. Martinez, “Ontogenesis of insulin receptors in human cerebral cortex,” Journal of Endocrinological Investigation, vol. 14, no. 1, pp. 53–58, 1991. View at Scopus
  221. L. Pawlikowska, D. Hu, S. Huntsman et al., “Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity,” Aging Cell, vol. 8, no. 4, pp. 460–472, 2009. View at Publisher · View at Google Scholar · View at Scopus
  222. A. Taguchi, L. M. Wartschow, and M. F. White, “Brain IRS2 signaling coordinates life span and nutrient homeostasis,” Science, vol. 317, no. 5836, pp. 369–372, 2007. View at Publisher · View at Google Scholar · View at Scopus
  223. H. Kurosu, M. Yamamoto, J. D. Clark et al., “Physiology: suppression of aging in mice by the hormone Klotho,” Science, vol. 309, no. 5742, pp. 1829–1833, 2005. View at Publisher · View at Google Scholar · View at Scopus
  224. D. Van Heemst, M. Beekman, S. P. Mooijaart et al., “Reduced insulin/IGF-1 signalling and human longevity,” Aging Cell, vol. 4, no. 2, pp. 79–85, 2005. View at Publisher · View at Google Scholar · View at Scopus
  225. M. Blüher, B. B. Kahn, and C. R. Kahn, “Extended longevity in mice lacking the insulin receptor in adipose tissue,” Science, vol. 299, no. 5606, pp. 572–574, 2003. View at Publisher · View at Google Scholar · View at Scopus
  226. A. Bartke, “Impact of reduced insulin-like growth factor-1/insulin signaling on aging in mammals: novel findings,” Aging Cell, vol. 7, no. 3, pp. 285–290, 2008. View at Publisher · View at Google Scholar · View at Scopus
  227. J. H. Hahm, S. Kim, and Y. K. Paik, “Endogenous cGMP regulates adult longevity via the insulin signaling pathway in Caenorhabditis elegans,” Aging Cell, vol. 8, no. 4, pp. 473–483, 2009. View at Publisher · View at Google Scholar · View at Scopus
  228. M. D. Nielsen, X. Luo, B. Biteau, K. Syverson, and H. Jasper, “14-3-3ε antagonizes FoxO to control growth, apoptosis and longevity in Drosophila,” Aging Cell, vol. 7, no. 5, pp. 688–699, 2008. View at Publisher · View at Google Scholar · View at Scopus
  229. L. Zhou, H. Chen, P. Xu et al., “Action of insulin receptor substrate-3 (IRS-3) and IRS-4 to stimulate translocation of GLUT4 in rat adipose cells,” Molecular Endocrinology, vol. 13, no. 3, pp. 505–514, 1999. View at Scopus
  230. L. Frittitta, R. Vigneri, M. R. Stampfer, and I. D. Goldfine, “Insulin receptor overexpression in 184B5 human mammary epithelial cells induces a ligand-dependent transformed phenotype,” Journal of Cellular Biochemistry, vol. 57, no. 4, pp. 666–669, 1995. View at Scopus
  231. M. Barbieri, M. Bonafè, C. Franceschi, and G. Paolisso, “Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans,” American Journal of Physiology, vol. 285, no. 5, pp. E1064–E1071, 2003.
  232. N. A. Bishop, T. Lu, and B. A. Yankner, “Neural mechanisms of ageing and cognitive decline,” Nature, vol. 464, no. 7288, pp. 529–535, 2010. View at Publisher · View at Google Scholar · View at Scopus
  233. J. M. Copeland, J. Cho, T. Lo et al., “Extension of Drosophila life span by RNAi of the mitochondrial respiratory chain,” Current Biology, vol. 19, no. 19, pp. 1591–1598, 2009. View at Publisher · View at Google Scholar · View at Scopus
  234. C. Dell'Agnello, S. Leo, A. Agostino et al., “Increased longevity and refractoriness to Ca2+-dependent neurodegeneration in Surf1 knockout mice,” Human Molecular Genetics, vol. 16, no. 4, pp. 431–444, 2007. View at Publisher · View at Google Scholar · View at Scopus
  235. R. Brookmeyer, E. Johnson, K. Ziegler-Graham, and H. M. Arrighi, “Forecasting the global burden of Alzheimer's disease,” Alzheimer's and Dementia, vol. 3, no. 3, pp. 186–191, 2007. View at Publisher · View at Google Scholar · View at Scopus
  236. D. J. Selkoe, “Translating cell biology into therapeutic advances in Alzheimer's disease,” Nature, vol. 399, pp. A23–A31, 1999. View at Scopus
  237. K. Uemura, A. Kuzuya, and S. Shimohama, “Protein trafficking and Alzheimer's disease,” Current Alzheimer Research, vol. 1, no. 1, pp. 1–10, 2004. View at Scopus
  238. E. Carro and I. Torres-Aleman, “The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease,” European Journal of Pharmacology, vol. 490, no. 1–3, pp. 127–133, 2004. View at Publisher · View at Google Scholar · View at Scopus
  239. A. Rocchi, S. Pellegrini, G. Siciliano, and L. Murri, “Causative and susceptibility genes for Alzheimer's disease: a review,” Brain Research Bulletin, vol. 61, no. 1, pp. 1–24, 2003. View at Publisher · View at Google Scholar · View at Scopus
  240. E. Grünblatt, E. Koutsilieri, S. Hoyer, and P. Riederer, “Gene expression alterations in brain areas of intracerebroventricular streptozotocin treated rat,” Journal of Alzheimer's Disease, vol. 9, no. 3, pp. 261–271, 2006. View at Scopus
  241. B. H. Anderton, “Ageing of the brain,” Mechanisms of Ageing and Development, vol. 123, no. 7, pp. 811–817, 2002. View at Publisher · View at Google Scholar · View at Scopus
  242. A. Eckert, U. Keil, C. A. Marques et al., “Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease,” Biochemical Pharmacology, vol. 66, no. 8, pp. 1627–1634, 2003. View at Publisher · View at Google Scholar
  243. G. Perry, M. A. Taddeo, R. B. Petersen et al., “Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease,” BioMetals, vol. 16, no. 1, pp. 77–81, 2003. View at Publisher · View at Google Scholar · View at Scopus
  244. D. A. Butterfield and D. Boyd-Kimball, “The critical role of methionine 35 in Alzheimer's amyloid β-peptide (1–42)-induced oxidative stress and neurotoxicity,” Biochimica et Biophysica Acta, vol. 1703, no. 2, pp. 149–156, 2005. View at Publisher · View at Google Scholar
  245. J. K. Andersen, “Oxidative stress in neurodegeneration: cause or consequence?” Nature Medicine, vol. 10, supplement, pp. S18–S25, 2004. View at Scopus
  246. P. Rinaldi, M. C. Polidori, A. Metastasio et al., “Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease,” Neurobiology of Aging, vol. 24, no. 7, pp. 915–919, 2003. View at Publisher · View at Google Scholar · View at Scopus
  247. Y. Gilgun-Sherki, E. Melamed, and D. Offen, “Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier,” Neuropharmacology, vol. 40, no. 8, pp. 959–975, 2001. View at Publisher · View at Google Scholar · View at Scopus
  248. M. A. Smith, L. M. Sayre, V. E. Anderson et al., “Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine,” Journal of Histochemistry and Cytochemistry, vol. 46, no. 6, pp. 731–735, 1998. View at Scopus
  249. P. P. Zandi, J. C. Anthony, A. S. Khachaturian et al., “Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County study,” Archives of Neurology, vol. 61, no. 1, pp. 82–88, 2004. View at Publisher · View at Google Scholar
  250. E. T. Klatte, D. W. Scharre, H. N. Nagaraja, R. A. Davis, and D. Q. Beversdorf, “Combination therapy of donepezil and vitamin E in Alzheimer disease,” Alzheimer Disease and Associated Disorders, vol. 17, no. 2, pp. 113–116, 2003. View at Publisher · View at Google Scholar · View at Scopus
  251. R. B. Maccioni, J. P. Muñoz, and L. Barbeito, “The molecular bases of Alzheimer's disease and other neurodegenerative disorders,” Archives of Medical Research, vol. 32, no. 5, pp. 367–381, 2001. View at Publisher · View at Google Scholar · View at Scopus
  252. B. Moosmann and C. Behl, “Antioxidants as treatment for neurodegenerative disorders,” Expert Opinion on Investigational Drugs, vol. 11, no. 10, pp. 1407–1435, 2002. View at Publisher · View at Google Scholar · View at Scopus
  253. J. A. Luchsinger, M. X. Tang, S. Shea, and R. Mayeux, “Antioxidant vitamin intake and risk of Alzheimer disease,” Archives of Neurology, vol. 60, no. 2, pp. 203–208, 2003. View at Publisher · View at Google Scholar · View at Scopus
  254. D. J. Piñero, J. Hu, and J. R. Connor, “Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains,” Cellular and Molecular Biology, vol. 46, no. 4, pp. 761–776, 2000. View at Scopus
  255. J. P. Blass, R. K. F. Sheu, and G. E. Gibson, “Inherent abnormalities in energy metabolism in Alzheimer disease: interaction with cerebrovascular compromise,” Annals of the New York Academy of Sciences, vol. 903, pp. 204–221, 2000. View at Scopus
  256. S. Hoyer, “Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis,” Journal of Neural Transmission, vol. 105, no. 4-5, pp. 415–422, 1998. View at Publisher · View at Google Scholar · View at Scopus
  257. H. Fukuyama, M. Ogawa, H. Yamauchi et al., “Altered cerebral energy metabolism in Alzheimer's disease: a PET study,” Journal of Nuclear Medicine, vol. 35, no. 1, pp. 1–6, 1994. View at Scopus
  258. G. W. Small, S. Komo, A. La Rue et al., “Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimaging,” Annals of the New York Academy of Sciences, vol. 802, pp. 70–78, 1996. View at Publisher · View at Google Scholar · View at Scopus
  259. S. Hoyer, “Glucose metabolism and insulin receptor signal transduction in Alzheimer disease,” European Journal of Pharmacology, vol. 490, no. 1–3, pp. 115–125, 2004. View at Publisher · View at Google Scholar · View at Scopus
  260. Y. Liu, F. Liu, K. Iqbal, I. Grundke-Iqbal, and C. X. Gong, “Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease,” FEBS Letters, vol. 582, no. 2, pp. 359–364, 2008. View at Publisher · View at Google Scholar · View at Scopus
  261. P. I. Moreira, M. S. Santos, and C. R. Oliveira, “Alzheimer's disease: a lesson from mitochondrial dysfunction,” Antioxidants and Redox Signaling, vol. 9, no. 10, pp. 1621–1630, 2007. View at Publisher · View at Google Scholar · View at Scopus
  262. G. E. Gibson, L. C.H. Park, K.-F. R. Sheu, J. P. Blass, and N. Y. Calingasan, “The α-ketoglutarate dehydrogenase complex in neurodegeneration,” Neurochemistry International, vol. 36, no. 2, pp. 97–112, 2000. View at Publisher · View at Google Scholar
  263. S. J. Kish, “Brain energy metabolizing enzymes in Alzheimer's disease: α-ketoglutarate dehydrogenase complex and cytochrome oxidase,” Annals of the New York Academy of Sciences, vol. 826, pp. 218–228, 1997. View at Publisher · View at Google Scholar · View at Scopus
  264. S. Sorbi, E. D. Bird, and J. P. Blass, “Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain,” Annals of Neurology, vol. 13, no. 1, pp. 72–78, 1983. View at Scopus
  265. P. Bubber, V. Haroutunian, G. Fisch, J. P. Blass, and G. E. Gibson, “Mitochondrial abnormalities in Alzheimer brain: mechanistic implications,” Annals of Neurology, vol. 57, no. 5, pp. 695–703, 2005. View at Publisher · View at Google Scholar · View at Scopus
  266. S. M. Cardoso, I. Santana, R. H. Swerdlow, and C. R. Oliveira, “Mitochondria dysfunction of Alzheimer's disease cybrids enhances Aβ toxicity,” Journal of Neurochemistry, vol. 89, no. 6, pp. 1417–1426, 2004. View at Publisher · View at Google Scholar · View at Scopus
  267. W. D. Parker, N. J. Mahr, C. M. Filley et al., “Reduced platelet cytochrome c oxidase activity in Alzheimer's disease,” Neurology, vol. 44, no. 6, pp. 1086–1090, 1994. View at Scopus
  268. E. M. Mutisya, A. C. Bowling, and M. F. Beal, “Cortical cytochrome oxidase activity is reduced in Alzheimer's disease,” Journal of Neurochemistry, vol. 63, no. 6, pp. 2179–2184, 1994. View at Scopus
  269. S. J. Kish, C. Bergeron, A. Rajput et al., “Brain cytochrome oxidase in Alzheimer's disease,” Journal of Neurochemistry, vol. 59, no. 2, pp. 776–779, 1992. View at Publisher · View at Google Scholar · View at Scopus
  270. R. E. Davis, S. Miller, C. Herrnstadt et al., “Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 9, pp. 4526–4531, 1997. View at Publisher · View at Google Scholar · View at Scopus
  271. R. H. Swerdlow, J. K. Parks, D. S. Cassarino et al., “Cybrids in Alzheimer's disease: a cellular model of the disease?” Neurology, vol. 49, no. 4, pp. 918–925, 1997. View at Scopus
  272. J. Valla, L. Schneider, T. Niedzielko et al., “Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment,” Mitochondrion, vol. 6, no. 6, pp. 323–330, 2006. View at Publisher · View at Google Scholar · View at Scopus
  273. R. Castellani, K. Hirai, G. Aliev et al., “Role of mitochondrial dysfunction in Alzheimer's disease,” Journal of Neuroscience Research, vol. 70, no. 3, pp. 357–360, 2002. View at Publisher · View at Google Scholar · View at Scopus
  274. H. Umegaki, “Pathophysiology of cognitive dysfunction in older people with type 2 diabetes: vascular changes or neurodegeneration?” Age and Ageing, vol. 39, no. 1, Article ID afp211, pp. 8–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  275. N. Rasgon and L. Jarvik, “Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis,” Journals of Gerontology A, vol. 59, no. 2, pp. 178–183, 2004. View at Scopus
  276. R. Peila, B. L. Rodriguez, and L. J. Launer, “Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study,” Diabetes, vol. 51, no. 4, pp. 1256–1262, 2002. View at Scopus
  277. A. Ott, R. P. Stolk, F. Van Harskamp, H. A. P. Pols, A. Hofman, and M. M. B. Breteler, “Diabetes mellitus and the risk of dementia: the Rotterdam study,” Neurology, vol. 53, no. 9, pp. 1937–1942, 1999. View at Scopus
  278. V. Rhein and A. Eckert, “Effects of Alzheimer’s amyloid-beta and tau protein on mitochondrial function—role of glucose metabolism and insulin signaling,” Archives of Physiology and Biochemistry, vol. 113, pp. 131–141, 2007.
  279. J. Janson, T. Laedtke, J. E. Parisi, P. O'Brien, R. C. Petersen, and P. C. Butler, “Increased risk of type 2 diabetes in Alzheimer disease,” Diabetes, vol. 53, no. 2, pp. 474–481, 2004. View at Publisher · View at Google Scholar · View at Scopus
  280. S. M. De La Monte and J. R. Wands, “Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 9, no. 2, pp. 167–181, 2006. View at Scopus
  281. N. Lester-Coll, E. J. Rivera, S. J. Soscia, K. Doiron, J. R. Wands, and S. M. De La Monte, “Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 9, no. 1, pp. 13–33, 2006. View at Scopus
  282. E. J. Rivera, A. Goldin, N. Fulmer, R. Tavares, J. R. Wands, and S. M. De La Monte, “Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine,” Journal of Alzheimer's Disease, vol. 8, no. 3, pp. 247–268, 2005. View at Scopus
  283. E. Steen, B. M. Terry, E. J. Rivera et al., “Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease—is this type 3 diabetes?” Journal of Alzheimer's Disease, vol. 7, no. 1, pp. 63–80, 2005. View at Scopus
  284. L. Frölich, D. Blum-Degen, P. Riederer, and S. Hoyer, “A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease,” Annals of the New York Academy of Sciences, vol. 893, pp. 290–293, 1999. View at Scopus
  285. M. Townsend, T. Mehta, and D. J. Selkoe, “Soluble Aβ inhibits specific signal transduction cascades common to the insulin receptor pathway,” Journal of Biological Chemistry, vol. 282, no. 46, pp. 33305–33312, 2007. View at Publisher · View at Google Scholar · View at Scopus
  286. W. Q. Zhao, F. G. De Felice, S. Fernandez et al., “Amyloid beta oligomers induce impairment of neuronal insulin receptors,” FASEB Journal, vol. 22, no. 1, pp. 246–260, 2008. View at Publisher · View at Google Scholar · View at Scopus
  287. C. J. Phiel, C. A. Wilson, V. M. Y. Lee, and P. S. Klein, “GSK-3α regulates production of Alzheimer's disease amyloid-β peptides,” Nature, vol. 423, no. 6938, pp. 435–439, 2003. View at Publisher · View at Google Scholar · View at Scopus
  288. L. Ho, W. Qin, P. N. Pompl et al., “Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease,” The FASEB Journal, vol. 18, no. 7, pp. 902–904, 2004. View at Scopus
  289. S. Freude, M. M. Hettich, C. Schumann et al., “Neuronal IGF-1 resistance reduces Aβ accumulation and protects against premature death in a model of Alzheimer's disease,” FASEB Journal, vol. 23, no. 10, pp. 3315–3324, 2009. View at Publisher · View at Google Scholar
  290. E. Carro, J. L. Trejo, C. Spuch, D. Bohl, J. M. Heard, and I. Torres-Aleman, “Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: new cues into the human disease?” Neurobiology of Aging, vol. 27, no. 11, pp. 1618–1631, 2005. View at Publisher · View at Google Scholar
  291. J. L. Trejo, E. Carro, E. Garcia-Galloway, and I. Torres-Aleman, “Role of insulin-like growth factor I signaling in neurodegenerative diseases,” Journal of Molecular Medicine, vol. 82, no. 3, pp. 156–162, 2004. View at Publisher · View at Google Scholar · View at Scopus
  292. J. L. Trejo, E. Carro, C. Lopez-Lopez, and I. Torres-Aleman, “Role of serum insulin-like growth factor I in mammalian brain aging,” Growth Hormone and IGF Research, vol. 14, pp. S39–S43, 2004. View at Scopus
  293. E. Planel, Y. Tatebayashi, T. Miyasaka et al., “Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms,” Journal of Neuroscience, vol. 27, no. 50, pp. 13635–13648, 2007. View at Publisher · View at Google Scholar · View at Scopus
  294. M. Schubert, D. P. Brazil, D. J. Burks et al., “Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation,” Journal of Neuroscience, vol. 23, no. 18, pp. 7084–7092, 2003. View at Scopus
  295. M. Hong and V. M. Y. Lee, “Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons,” Journal of Biological Chemistry, vol. 272, no. 31, pp. 19547–19553, 1997. View at Publisher · View at Google Scholar · View at Scopus
  296. A. Jämsä, K. Hasslund, R. F. Cowburn, A. Bäckström, and M. Vasänge, “The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation,” Biochemical and Biophysical Research Communications, vol. 319, no. 3, pp. 993–1000, 2004. View at Publisher · View at Google Scholar
  297. M. Lesort and G. V. W. Johnson, “Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons,” Neuroscience, vol. 99, no. 2, pp. 305–316, 2000. View at Publisher · View at Google Scholar · View at Scopus
  298. C. Benedict, W. H. Frey, H. B. Schioth, B. Schultes, J. Born, and M. Hallschmid, “Intranasal insulin as a therapeutic option in the treatment of cognitive impairments,” Experimental Gerontology, vol. 46, no. 2-3, pp. 112–115, 2011. View at Publisher · View at Google Scholar
  299. M. A. Reger, G. S. Watson, P. S. Green et al., “Intranasal insulin improves cognition and modulates β-amyloid in early AD,” Neurology, vol. 70, no. 6, pp. 440–448, 2008. View at Publisher · View at Google Scholar · View at Scopus
  300. M. A. Reger, G. S. Watson, W. H. Frey et al., “Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype,” Neurobiology of Aging, vol. 27, no. 3, pp. 451–458, 2006. View at Publisher · View at Google Scholar · View at Scopus
  301. S. Craft, L. D. Baker, T. J. Montine, et al., “Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial,” Archives of Neurology, vol. 69, no. 1, pp. 29–38, 2012.
  302. M. E. Risner, A. M. Saunders, J. F. B. Altman et al., “Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease,” Pharmacogenomics Journal, vol. 6, no. 4, pp. 246–254, 2006. View at Publisher · View at Google Scholar
  303. G. S. Watson, B. A. Cholerton, M. A. Reger et al., “Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study,” American Journal of Geriatric Psychiatry, vol. 13, no. 11, pp. 950–958, 2005. View at Publisher · View at Google Scholar · View at Scopus
  304. G. M. Salituro, F. Pelaez, and B. B. Zhang, “Discovery of a small molecule insulin receptor activator,” Recent Progress in Hormone Research, vol. 56, pp. 107–126, 2001. View at Publisher · View at Google Scholar · View at Scopus